Literature DB >> 22001697

Longitudinal analysis of gene expression and behaviour in the HdhQ150 mouse model of Huntington's disease.

Peter Giles1, Lyn Elliston, Gemma V Higgs, Simon P Brooks, Stephen B Dunnett, Lesley Jones.   

Abstract

Substantial transcriptional changes are seen in Huntington's disease (HD) brain and parallel early changes in gene expression are observed in mouse models of HD. Analysis of behaviour in such models also shows substantial deficits in motor, learning and memory tasks. We examined the changes in the transcriptional profile in the HdhQ150 mouse model of HD at 6, 12 and 18 months and correlated these changes with the behavioural tasks the animals had undertaken. Changes in gene expression over time showed a significant enrichment of RNAs altered in abundance that related to cognition in both HdhQ150 and wild-type animals. The most significantly down-regulated mRNA between genotypes over the whole time-course was Htt itself. Other changes between genotypes identified at 6 months related to chromatin organization and structure, whilst at 18 months changes related mainly to intracellular signalling. Correlation of the changes in gene product abundance with phenotypic changes revealed that weight and detection of the opposite position of the platform in the water maze seemed to correlate with the chromatin alterations whereas changes in the rotarod performance related mainly to intracellular signalling and homeostasis. These results implicate alterations in specific molecular pathways that may underpin changes in different behavioural tasks.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001697     DOI: 10.1016/j.brainresbull.2011.10.001

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  12 in total

1.  Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.

Authors:  Biswarathan Ramani; Bharat Panwar; Lauren R Moore; Bo Wang; Rogerio Huang; Yuanfang Guan; Henry L Paulson
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

2.  Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease.

Authors:  Kirupa Sathasivam; Andreas Neueder; Theresa A Gipson; Christian Landles; Agnesska C Benjamin; Marie K Bondulich; Donna L Smith; Richard L M Faull; Raymund A C Roos; David Howland; Peter J Detloff; David E Housman; Gillian P Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

3.  Similar striatal gene expression profiles in the striatum of the YAC128 and HdhQ150 mouse models of Huntington's disease are not reflected in mutant Huntingtin inclusion prevalence.

Authors:  Zubeyde Bayram-Weston; Timothy C Stone; Peter Giles; Linda Elliston; Nari Janghra; Gemma V Higgs; Peter A Holmans; Stephen B Dunnett; Simon P Brooks; Lesley Jones
Journal:  BMC Genomics       Date:  2015-12-21       Impact factor: 3.969

4.  Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the HdhQ150/Q150 Mouse Model of Huntington's Disease.

Authors:  Ivan Rattray; Edward J Smith; William R Crum; Thomas A Walker; Richard Gale; Gillian P Bates; Michel Modo
Journal:  PLoS One       Date:  2017-01-18       Impact factor: 3.240

5.  Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels.

Authors:  Steve Horvath; Peter Langfelder; Seung Kwak; Jeff Aaronson; Jim Rosinski; Thomas F Vogt; Marika Eszes; Richard L M Faull; Maurice A Curtis; Henry J Waldvogel; Oi-Wa Choi; Spencer Tung; Harry V Vinters; Giovanni Coppola; X William Yang
Journal:  Aging (Albany NY)       Date:  2016-07       Impact factor: 5.682

6.  Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice.

Authors:  Peter Langfelder; Jeffrey P Cantle; Doxa Chatzopoulou; Nan Wang; Fuying Gao; Ismael Al-Ramahi; Xiao-Hong Lu; Eliana Marisa Ramos; Karla El-Zein; Yining Zhao; Sandeep Deverasetty; Andreas Tebbe; Christoph Schaab; Daniel J Lavery; David Howland; Seung Kwak; Juan Botas; Jeffrey S Aaronson; Jim Rosinski; Giovanni Coppola; Steve Horvath; X William Yang
Journal:  Nat Neurosci       Date:  2016-02-22       Impact factor: 24.884

Review 7.  Mouse models of polyglutamine diseases: review and data table. Part I.

Authors:  Maciej Figiel; Wojciech J Szlachcic; Pawel M Switonski; Agnieszka Gabka; Wlodzimierz J Krzyzosiak
Journal:  Mol Neurobiol       Date:  2012-09-07       Impact factor: 5.590

8.  Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/1 mouse model of Huntington's disease.

Authors:  Ivan Rattray; Edward J Smith; William R Crum; Thomas A Walker; Richard Gale; Gillian P Bates; Michel Modo
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

9.  Transcriptional regulatory networks underlying gene expression changes in Huntington's disease.

Authors:  Seth A Ament; Jocelynn R Pearl; Jeffrey P Cantle; Robert M Bragg; Peter J Skene; Sydney R Coffey; Dani E Bergey; Vanessa C Wheeler; Marcy E MacDonald; Nitin S Baliga; Jim Rosinski; Leroy E Hood; Jeffrey B Carroll; Nathan D Price
Journal:  Mol Syst Biol       Date:  2018-03-26       Impact factor: 11.429

10.  Early alteration of epigenetic-related transcription in Huntington's disease mouse models.

Authors:  Irati Hervás-Corpión; Deisy Guiretti; Manuel Alcaraz-Iborra; Román Olivares; Antonio Campos-Caro; Ángel Barco; Luis M Valor
Journal:  Sci Rep       Date:  2018-07-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.